Exemptia 40mg

Exemptia 40mg (Adalimumab) 40mg Injection is a prescription medication used to treat various conditions, including:

• Rheumatoid Arthritis (RA): a chronic autoimmune disease that causes inflammation and joint pain
• Psoriatic Arthritis (PsA): a form of arthritis that occurs in people with psoriasis
• Crohn’s Disease and Ulcerative Colitis: inflammatory bowel diseases (IBDs) that cause inflammation and damage in the digestive tract
• Plaque Psoriasis: a chronic skin condition characterized by red, scaly patches

Composition:

Each vial of Exemptia contains 40mg of adalimumab, a tumor necrosis factor (TNF) inhibitor that works by blocking the activity of TNF, a protein that promotes inflammation.

Mechanism of Action:

Adalimumab works by:

• Inhibiting the activity of TNF, which reduces inflammation and joint damage
• Slowing down the progression of joint damage and improving symptoms in RA and PsA
• Reducing the severity of Crohn’s disease and ulcerative colitis symptoms
• Clearing up psoriasis plaques

Indications:

Exemptia is indicated for the treatment of:

• Rheumatoid Arthritis (RA)
• Psoriatic Arthritis (PsA)
• Crohn’s Disease
• Ulcerative Colitis
• Plaque Psoriasis

Administration:

Exemptia is administered as an injection under the skin (subcutaneously) or intravenously. The dosage and administration schedule vary depending on the condition being treated.

Side Effects:

Common side effects of Exemptia include:

• Injection site reactions (redness, swelling, itching)
• Headache
• Fatigue
• Musculoskeletal pain
• Nasopharyngitis (stuffy nose, runny nose)
• Upper respiratory infections

Rare but serious side effects include:

• Increased risk of infection
• Serious allergic reactions
• Tuberculosis reactivation
• Lupus-like syndrome

Contraindications:

Exemptia is contraindicated in patients with:

• Active tuberculosis or a history of latent TB
• Severe hypersensitivity to adalimumab or any component of the product
• Moderate to severe active infections
• History of Crohn’s disease or ulcerative colitis with fistulas or abdominal abscesses

Precautions:

Patients with a history of TB or other infections should be closely monitored while using Exemptia. Patients with a history of lymphoma or other blood disorders should be closely monitored for changes in their blood counts.

Interactions:

Exemptia may interact with other medications, including:

• Biologics and immunosuppressive agents
• Corticosteroids
• Methotrexate
• Other medications that affect the immune system

Important Note:

Exemptia should be administered by a healthcare professional in a clinical setting. Patients should be monitored regularly for changes in their symptoms and side effects.